Bracco Imaging Scandinavia AB is a pharmaceutical company established in 1927, recognized as a leading authority in prevention and precision imaging. The company emphasizes sustainability and eco-friendly practices, which has earned it the EcoVadis Gold Medal for its sustainability efforts. Bracco Imaging has a direct presence in the Japanese market and has received marketing authorization for its product Vueway® (gadopiclenol), which is used in medical imaging.
In addition to its product offerings, Bracco Imaging has formed a partnership with ulrich medical to develop Syringeless MR Injectors. The company is also active in educational initiatives, hosting webinars focused on artificial intelligence in medical writing. Furthermore, it participates in the EuSoMII/Bracco AI Contest, which aims to advance the integration of AI in medical imaging. Bracco Imaging promotes a circular healthcare economy through its 'Re.Viva' initiative and is recognized as a Historical Trademark of National Interest.